Investment analysts at William Blair initiated coverage on shares of Twist Bioscience (NASDAQ:TWST) in a note issued to investors on Tuesday, Briefing.com reports. The firm set an "outperform" rating on the stock.
https://www.marketbeat.com/instant-alerts/nasdaq-twst-a-buy-or-sell-right-now-2021-06-2-3/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.